Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Myeloid-Derived Suppressor Phenotype of Leukemic Blasts in Association with Increased Suppressor T Cell Subsets in Acute Myelogenous Leukemia– Evidence for Immunoediting.

Sawa Ito, MD, Stephen A. Strickland, MD, MSCI, Bipin N. Savani, MD, J. Joseph Melenhorst, Ph.D., Fang Yin, MD, Pawel Muranski, MD, Nancy F. Hensel, BS, Fariba Chinian, M.S., Keyvan Keyvanfar, BS, Christopher S. Hourigan, MD, PhD, Minoo Battiwalla, MD, MS, A. John Barrett, MD

Blood (2012) 120 (21): 2528.

https://doi.org/10.1182/blood.V120.21.2528.2528

Published: 2012

Journal Articles

Ultra-Low Dose IL-2 Safely Expands Regulatory T Cells and CD56 bright NK Cells in Healthy Volunteers: Towards Safer Stem Cell Donors?

Sawa Ito, MD, Minoo Battiwalla, MD, MS, J. Joseph Melenhorst, Ph.D., Mattias Carlsten, MD Ph.D, Angelique Biancotto, PhD, Ena Wang, M.D., Zhi Xie, Ph.D., Pawel Muranski, MD, Matthew J. Olnes, MD, PhD, Kazushi Tanimoto, MD, Paula Schum, R.N., Shira Perl, MD, Howard Dickler, MD, J. Philip McCoy, PhD, Thomas Hughes, Pharm D, Leodayan Bojanowski, DNP, CIP, RN, Nancy F. Hensel, BS, Neal S. Young, MD, A. John Barrett, MD

Blood (2012) 120 (21): 3283.

https://doi.org/10.1182/blood.V120.21.3283.3283

Published: 2012

Journal Articles

Long Term Maintenance of Myeloid Leukemia Stem Cell-Like Populations Cultured with Mesenchymal Stromal Cells (MSC)

Sawa Ito, MD, A. John Barrett, MD, Andre Larochelle, M.D., Ph.D., Nancy F. Hensel, BS, Keyvan Keyvanfar, BS, J. Joseph Melenhorst, Ph.D.

Blood (2012) 120 (21): 3546.

https://doi.org/10.1182/blood.V120.21.3546.3546

Published: 2012

Journal Articles

Abrogation of Myeloid Derived Suppressor Cell-Like Inhibitory Activity of K562 Restores Antigen Presenting Cell Functions

Kazushi Tanimoto, MD, PhD, Pawel Muranski, MD, Nancy F. Hensel, BS, Keyvan Keyvanfar, BS, Hiroshi Fujiwara, MD, PhD, A. John Barrett, MD, J. Joseph Melenhorst, PhD

Blood (2012) 120 (21): 4118.

https://doi.org/10.1182/blood.V120.21.4118.4118

Published: 2012

Journal Articles

Improved Strategy for Rapid Generation of Quadrivirus-Specific CD8+ and CD4+ Cytotoxic T Lymphocytes (CTLs) for Adoptive Transfer After Stem Cell Transplantation (SCT)

Alexandros Spyridonidis, MD, Pawel Muranski, MD, Sid Kerkar, MD, Kazushi Tanimoto, MD, Nancy F. Hensel, BS, J. Joseph Melenhorst, PhD, A. John Barrett, MD

Blood (2012) 120 (21): 4121.

https://doi.org/10.1182/blood.V120.21.4121.4121

Published: 2012

Journal Articles

Second Stem Cell Transplantation (SCT) for Relapsed Leukemia Provides Only Modest Prolongation of Survival

Zachariah A. McIver, DO, Thomas Hughes, Pharm D, Sawa Ito, MD, Minoo Battiwalla, MD, MS, Eleftheria K. Koklanaris, BSN, Janice Haggerty, RN, Nancy F. Hensel, BS, A. John Barrett, MD

Blood (2011) 118 (21): 2001.

https://doi.org/10.1182/blood.V118.21.2001.2001

Published: 2011

Journal Articles

Low Thymic Natural Regulatory T Cell Output in the Donor Is Associated with An Increased Incidence of Extensive Chronic GvHD After T Cell Depleted Matched Sibling Stem Cell Transplantation (SCT)

Zachariah A. McIver, DO, J. Joseph Melenhorst, PhD, Haiyun Zheng, Colin O. Wu, PhD, Andrew Grim, BS, Sawa Ito, MD, Irene Cho, BS, Nancy F. Hensel, BS, A. John Barrett, MD, FRCP, FRCPath

Blood (2011) 118 (21): 328.

https://doi.org/10.1182/blood.V118.21.328.328

Published: 2011

Journal Articles

Generation of Multi-Antigen Specific T Cells for Adoptive Immunotherapy of Myeloid Leukemia and Identification of MHC Class I and II-Restricted Peptides for WT1, Proteinase 3 and Human Neutrophil Elastase

Gerrit Weber, MD, Ulrike Gerdemann, MD, Nancy F. Hensel, BS, Ann M. Leen, PhD, Catherine M. Bollard, MD, A. John Barrett, MD

Blood (2011) 118 (21): 2985.

https://doi.org/10.1182/blood.V118.21.2985.2985

Published: 2011

Journal Articles

Evolution of the Donor T Cell Repertoire In Allogeneic Stem Cell Transplant Recipients In the Second Decade After Transplantation

Robert Q. Le, MD, PhD, J. Joseph Melenhorst, PhD, Brenna Hill, MPhil, Sarfraz Memon, MD, Minoo Battiwalla, MD, MS, Bipin N. Savani, MD, Aarthi Shenoy, MD, Nancy F. Hensel, BS, Eleftheria K. Koklanaris, RN, BS, Keyvan Keyvanfar, BS, Frances T. Hakim, PhD, Daniel C. Douek, MD, PhD, A. John Barrett, MD, FRCP, FRCPath

Blood (2010) 116 (21): 831.

https://doi.org/10.1182/blood.V116.21.831.831

Published: 2010

Journal Articles

Peptide-Major Histocompatibility Complex Class I Tetramers with Enhanced Coreceptor Binding Properties Enable Visualization of Low Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells.

J. Joseph Melenhorst, PhD, Phillip Scheinberg, MD, Emma Gostick, BS, Pratip K. Chattopadhyay, PhD, Anna Lissina, BS, David K. Cole, PhD, Mario Roederer, PhD, Ethan Bornstein, MS, Nancy F. Hensel, BS, Daniel C. Douek, MD, PhD, Andrew K. Sewell, PhD, A. John Barrett, MD, David A. Price, MD, PhD

Blood (2007) 110 (11): 1343.

https://doi.org/10.1182/blood.V110.11.1343.1343

Published: 2007

Journal Articles

High Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells Preferentially Localize to the Bone Marrow in Patients with Myeloid Malignancies.

J. Jopseph Melenhorst, PhD, Phillip Scheinberg, MD, Pratip K. Chattopadhyay, PhD, Emma Gostick, BS, Mario Roederer, PhD, Nancy F. Hensel, BS, Daniel C. Douek, MD, PhD, A. John Barrett, MD, David A. Price, MD, PhD

Blood (2007) 110 (11): 2763.

https://doi.org/10.1182/blood.V110.11.2763.2763

Published: 2007

NARROW

Myeloid-Derived Suppressor Phenotype of Leukemic Blasts in Association with Increased Suppressor T Cell Subsets in Acute Myelogenous Leukemia– Evidence for Immunoediting.

Ultra-Low Dose IL-2 Safely Expands Regulatory T Cells and CD56 bright NK Cells in Healthy Volunteers: Towards Safer Stem Cell Donors?

Long Term Maintenance of Myeloid Leukemia Stem Cell-Like Populations Cultured with Mesenchymal Stromal Cells (MSC)

Abrogation of Myeloid Derived Suppressor Cell-Like Inhibitory Activity of K562 Restores Antigen Presenting Cell Functions

Improved Strategy for Rapid Generation of Quadrivirus-Specific CD8+ and CD4+ Cytotoxic T Lymphocytes (CTLs) for Adoptive Transfer After Stem Cell Transplantation (SCT)

Second Stem Cell Transplantation (SCT) for Relapsed Leukemia Provides Only Modest Prolongation of Survival

Low Thymic Natural Regulatory T Cell Output in the Donor Is Associated with An Increased Incidence of Extensive Chronic GvHD After T Cell Depleted Matched Sibling Stem Cell Transplantation (SCT)

Generation of Multi-Antigen Specific T Cells for Adoptive Immunotherapy of Myeloid Leukemia and Identification of MHC Class I and II-Restricted Peptides for WT1, Proteinase 3 and Human Neutrophil Elastase

Evolution of the Donor T Cell Repertoire In Allogeneic Stem Cell Transplant Recipients In the Second Decade After Transplantation

Peptide-Major Histocompatibility Complex Class I Tetramers with Enhanced Coreceptor Binding Properties Enable Visualization of Low Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells.

High Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells Preferentially Localize to the Bone Marrow in Patients with Myeloid Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only